Literature DB >> 8325898

Structure-function analysis of interleukin-6 utilizing human/murine chimeric molecules. Involvement of two separate domains in receptor binding.

M van Dam1, J Müllberg, H Schooltink, T Stoyan, J P Brakenhoff, L Graeve, P C Heinrich, S Rose-John.   

Abstract

As an approach to understanding the interaction of interleukin-6 (IL-6) and its 80-kDa receptor (gp80), we have constructed chimeric human/murine IL-6-molecules, which were expressed in Escherichia coli and analyzed for biological activity and receptor binding. This experimental strategy was based on the observation that human IL-6 acts on human and murine cells, whereas murine IL-6 stimulates only murine cells. The regions to be exchanged were chosen according to the four antiparallel helix model of the hematopoietic cytokine family. All 14 chimeras constructed showed biological activity on murine cells. From the differential biological activities on human cells we deduced that three out of four domains of IL-6 are involved in species specificity, whereas only two domains are necessary for specific recognition by the gp80 IL-6-receptor protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8325898

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Stabilized Interleukin-6 receptor binding RNA aptamers.

Authors:  Cindy Meyer; Katharina Berg; Katja Eydeler-Haeder; Inken Lorenzen; Joachim Grötzinger; Stefan Rose-John; Ulrich Hahn
Journal:  RNA Biol       Date:  2013-12-20       Impact factor: 4.652

2.  Transcriptional activation of the small GTPase gene rhoB by genotoxic stress is regulated via a CCAAT element.

Authors:  G Fritz; B Kaina
Journal:  Nucleic Acids Res       Date:  2001-02-01       Impact factor: 16.971

Review 3.  Interleukin-6: structure-function relationships.

Authors:  R J Simpson; A Hammacher; D K Smith; J M Matthews; L D Ward
Journal:  Protein Sci       Date:  1997-05       Impact factor: 6.725

4.  Human herpesvirus 8 encodes a homolog of interleukin-6.

Authors:  F Neipel; J C Albrecht; A Ensser; Y Q Huang; J J Li; A E Friedman-Kien; B Fleckenstein
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

5.  Human ciliary neurotrophic factor: a structure-function analysis.

Authors:  A Krüttgen; J Grötzinger; G Kurapkat; J Weis; R Simon; M Thier; M Schröder; P Heinrich; A Wollmer; M Comeau
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

6.  Hepatocellular hyperplasia, plasmacytoma formation, and extramedullary hematopoiesis in interleukin (IL)-6/soluble IL-6 receptor double-transgenic mice.

Authors:  P Schirmacher; M Peters; G Ciliberto; M Blessing; J Lotz; K H Meyer zum Büschenfelde; S Rose-John
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

7.  Trp53 deficiency protects against acute intestinal inflammation.

Authors:  Martina E Spehlmann; Carolin F Manthey; Sara M Dann; Elaine Hanson; Sukhman S Sandhu; Linus Y Liu; Farid K Abdelmalak; Michaela A Diamanti; Kristin Retzlaff; Jürgen Scheller; Stefan Rose-John; Florian R Greten; Jean Y J Wang; Lars Eckmann
Journal:  J Immunol       Date:  2013-06-14       Impact factor: 5.422

8.  Unraveling viral interleukin-6 binding to gp130 and activation of STAT-signaling pathways independently of the interleukin-6 receptor.

Authors:  Nina Adam; Björn Rabe; Jan Suthaus; Joachim Grötzinger; Stefan Rose-John; Jürgen Scheller
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

9.  Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells.

Authors:  N J Sullivan; A K Sasser; A E Axel; F Vesuna; V Raman; N Ramirez; T M Oberyszyn; B M Hall
Journal:  Oncogene       Date:  2009-07-06       Impact factor: 9.867

10.  Structure-function analysis of human IL-6: identification of two distinct regions that are important for receptor binding.

Authors:  A Hammacher; L D Ward; J Weinstock; H Treutlein; K Yasukawa; R J Simpson
Journal:  Protein Sci       Date:  1994-12       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.